Healthequity (HQY) Stock Rating Upgraded by BidaskClub

BidaskClub upgraded shares of Healthequity (NASDAQ:HQY) from a hold rating to a buy rating in a research note published on Friday.

A number of other equities analysts have also recently weighed in on HQY. Zacks Investment Research raised shares of Healthequity from a hold rating to a buy rating and set a $57.00 price target on the stock in a research note on Saturday, February 10th. Robert W. Baird upped their price target on shares of Healthequity from $48.00 to $49.00 and gave the stock a neutral rating in a research note on Wednesday, February 7th. Cantor Fitzgerald upped their price target on shares of Healthequity from $56.00 to $60.00 and gave the stock an overweight rating in a research note on Wednesday, February 7th. JPMorgan Chase & Co. lowered their price objective on shares of Healthequity from $52.00 to $51.00 and set an overweight rating on the stock in a research note on Wednesday, January 24th. Finally, Chardan Capital increased their price objective on shares of Healthequity from $58.00 to $62.00 and gave the company a buy rating in a research note on Wednesday, December 6th. One equities research analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. Healthequity presently has an average rating of Buy and an average price target of $56.67.

Healthequity (NASDAQ HQY) opened at $54.86 on Friday. Healthequity has a 12 month low of $37.62 and a 12 month high of $55.34. The firm has a market cap of $3,328.50, a price-to-earnings ratio of 78.37, a PEG ratio of 2.09 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The business had revenue of $56.80 million for the quarter, compared to analysts’ expectations of $55.27 million. During the same period in the prior year, the company posted $0.10 EPS. The business’s revenue for the quarter was up 31.0% on a year-over-year basis. research analysts predict that Healthequity will post 0.73 EPS for the current year.

In other Healthequity news, insider Jon Kessler sold 20,442 shares of the firm’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $55.02, for a total transaction of $1,124,718.84. Following the sale, the insider now directly owns 446,332 shares of the company’s stock, valued at approximately $24,557,186.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Berkley Capital, Llc sold 700 shares of the firm’s stock in a transaction dated Wednesday, November 29th. The stock was sold at an average price of $52.05, for a total transaction of $36,435.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 809,521 shares of company stock worth $41,607,680. 19.00% of the stock is owned by corporate insiders.

Several institutional investors have recently added to or reduced their stakes in the business. BlackRock Inc. boosted its stake in shares of Healthequity by 3.8% during the 4th quarter. BlackRock Inc. now owns 6,751,491 shares of the company’s stock worth $315,026,000 after purchasing an additional 244,819 shares during the last quarter. State Street Corp boosted its stake in shares of Healthequity by 10.8% during the 2nd quarter. State Street Corp now owns 1,172,117 shares of the company’s stock worth $58,411,000 after purchasing an additional 114,294 shares during the last quarter. Eagle Asset Management Inc. boosted its stake in shares of Healthequity by 58.6% during the 4th quarter. Eagle Asset Management Inc. now owns 1,136,645 shares of the company’s stock worth $53,206,000 after purchasing an additional 419,914 shares during the last quarter. Wells Fargo & Company MN boosted its stake in shares of Healthequity by 49.5% during the 3rd quarter. Wells Fargo & Company MN now owns 1,108,410 shares of the company’s stock worth $56,063,000 after purchasing an additional 366,925 shares during the last quarter. Finally, Victory Capital Management Inc. boosted its stake in shares of Healthequity by 116.4% during the 4th quarter. Victory Capital Management Inc. now owns 1,031,711 shares of the company’s stock worth $48,139,000 after purchasing an additional 555,027 shares during the last quarter. 99.47% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: This report was posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this report on another site, it was copied illegally and reposted in violation of international trademark and copyright law. The correct version of this report can be read at https://stocknewstimes.com/2018/02/19/healthequity-hqy-stock-rating-upgraded-by-bidaskclub.html.

Healthequity Company Profile

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply